Tirzepatide is a dual GIP and GLP-1 receptor agonist that enhances insulin secretion, reduces appetite and promotes weight loss.
Recommended for:
- patients with type 2 diabetes for glycaemic control
- obese patients for weight management
- individuals with metabolic syndrome
- patients not achieving adequate control with standard therapy
Studies:
According to SURPASS and SURMOUNT trials, Tirzepatide demonstrated significant HbA1c reduction and weight loss compared to other GLP-1 receptor agonists.
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)